Resultados de la búsqueda 321-330 of 2153 for cannabis

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are unknown ...

8. Hiedra venenosa con bayas - Mayo Clinic

   Algunas hojas poseen bordes lisos, mientras que otras poseen una apariencia irregular como los bordes de una dentadura. En otoño, las hojas pueden volverse ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Further, these gains have been the result of interventions during the Consolidation (tandem autologous stem cell transplant) and Post-Consolidation (dinutuximab ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...